ID

20671

Description

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX); ODM derived from: https://clinicaltrials.gov/show/NCT00377858

Lien

https://clinicaltrials.gov/show/NCT00377858

Mots-clés

Versions (1)
  1. 09/03/2017 09/03/2017 -
Téléchargé le

9 mars 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus, Type 2 NCT00377858

Anglais

Eligibility Diabetes Mellitus, Type 2 NCT00377858

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
have type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
have been receiving oral antihyperglycemic medications (oam) without insulin including at least two of the following at maximally tolerated doses, and meet the minimum dosing criteria shown: metformin 1500 mg/day, sulfonylurea 1/2 the maximum daily dose, according to package insert, thiazolidinedione (tzd) 30 mg/day pioglitazone or 4 mg/day rosiglitazone. the oams also must be used in accordance with the product label
Description

Hypoglycemic Agents Oral | Insulin | Metformin U/day | Sulfonylurea Daily Dose | Thiazolidinediones | pioglitazone U/day | rosiglitazone U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020616
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0021641
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0456683
UMLS CUI [4,1]
C0038766
UMLS CUI [4,2]
C2348070
UMLS CUI [5]
C1257987
UMLS CUI [6,1]
C0071097
UMLS CUI [6,2]
C0456683
UMLS CUI [7,1]
C0289313
UMLS CUI [7,2]
C0456683
have a hemoglobin a1c greater than or equal to 7.5% and less than or equal to 12.0%.
Description

Glycosylated hemoglobin A Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C0439165
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
are taking a tzd dose greater than what is indicated in combination with insulin according to the tzd label.
Description

Thiazolidinediones High dose | Insulin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1257987
UMLS CUI [1,2]
C0444956
UMLS CUI [2]
C0021641
are taking any other glucose-lowering agents not mentioned in inclusion criterion.
Description

Hypoglycemic Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0020616
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks or for a total of 30 days or more in the last 24 weeks.
Description

Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide

Type de données

boolean

Alias
UMLS CUI [1]
C0050393
UMLS CUI [2]
C0066535
UMLS CUI [3]
C0537551
UMLS CUI [4]
C0167117
UMLS CUI [5]
C0246689
UMLS CUI [6]
C0903898
have a body mass index greater than 40 kg/m2.
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
have had more than one episode of severe hypoglycemia in the last24 weeks
Description

Hypoglycemia Severe Episode Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332189
UMLS CUI [1,4]
C1265611
are pregnant, intend to be pregnant during the course of the study or are breastfeeding
Description

Pregnancy | Pregnancy, Planned | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
have clinically significant cardiac, renal, hematologic, oncologic, or hepatic disease
Description

Heart Disease | Kidney Disease | Hematological Disease | Malignant Neoplasm | Liver disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0018939
UMLS CUI [4]
C0006826
UMLS CUI [5]
C0023895
Retour au début de la page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00377858

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
have type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Hypoglycemic Agents Oral | Insulin | Metformin U/day | Sulfonylurea Daily Dose | Thiazolidinediones | pioglitazone U/day | rosiglitazone U/day
Item
have been receiving oral antihyperglycemic medications (oam) without insulin including at least two of the following at maximally tolerated doses, and meet the minimum dosing criteria shown: metformin 1500 mg/day, sulfonylurea 1/2 the maximum daily dose, according to package insert, thiazolidinedione (tzd) 30 mg/day pioglitazone or 4 mg/day rosiglitazone. the oams also must be used in accordance with the product label
boolean
C0020616 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
C0038766 (UMLS CUI [4,1])
C2348070 (UMLS CUI [4,2])
C1257987 (UMLS CUI [5])
C0071097 (UMLS CUI [6,1])
C0456683 (UMLS CUI [6,2])
C0289313 (UMLS CUI [7,1])
C0456683 (UMLS CUI [7,2])
Glycosylated hemoglobin A Percentage
Item
have a hemoglobin a1c greater than or equal to 7.5% and less than or equal to 12.0%.
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Thiazolidinediones High dose | Insulin
Item
are taking a tzd dose greater than what is indicated in combination with insulin according to the tzd label.
boolean
C1257987 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
Hypoglycemic Agents
Item
are taking any other glucose-lowering agents not mentioned in inclusion criterion.
boolean
C0020616 (UMLS CUI [1])
Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide
Item
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks or for a total of 30 days or more in the last 24 weeks.
boolean
C0050393 (UMLS CUI [1])
C0066535 (UMLS CUI [2])
C0537551 (UMLS CUI [3])
C0167117 (UMLS CUI [4])
C0246689 (UMLS CUI [5])
C0903898 (UMLS CUI [6])
Body mass index
Item
have a body mass index greater than 40 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Hypoglycemia Severe Episode Quantity
Item
have had more than one episode of severe hypoglycemia in the last24 weeks
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
are pregnant, intend to be pregnant during the course of the study or are breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Heart Disease | Kidney Disease | Hematological Disease | Malignant Neoplasm | Liver disease
Item
have clinically significant cardiac, renal, hematologic, oncologic, or hepatic disease
boolean
C0018799 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C0006826 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial